[Role of aldosterone in oxidative stress and renal injury]

Area of Science:

• Cardiovascular research
• Renal physiology
• Oxidative stress mechanisms

Background:

• Mineralocorticoid receptor (MR) antagonists show promise for cardiovascular and renal protection.
• Aldosterone/salt treatment in rats causes significant cardiac and renal damage.
• This damage correlates with increased NADPH oxidase components and reactive oxygen species (ROS).

Purpose of the Study:

• To investigate the role of the aldosterone/MR pathway in cardiovascular and renal injuries.
• To determine the involvement of NADPH oxidase-dependent ROS production in aldosterone-induced organ damage.
• To evaluate the protective effects of the MR antagonist eplerenone.

Main Methods:

• Chronic aldosterone/salt administration in a rat model.
• In vitro studies using cultured vascular smooth muscle cells, glomerular mesangial cells, and renal fibroblasts.
• Measurement of NADPH oxidase activity, ROS levels, and superoxide generation.
• Assessment of organ injury and cell damage.

Main Results:

• Aldosterone/salt treatment led to severe cardiac and renal injuries in rats.
• These injuries were linked to elevated NADPH oxidase components and ROS.
• Eplerenone treatment prevented ROS increases and ameliorated organ damage.
• In vitro, aldosterone induced cell injury via NADPH oxidase and superoxide generation, which was attenuated by eplerenone.

Conclusions:

• The aldosterone/MR pathway is implicated in the pathogenesis of cardiovascular and renal injuries.
• NADPH oxidase-dependent ROS production is a key mechanism in aldosterone-induced organ damage.
• Selective MR antagonism, exemplified by eplerenone, offers a potential therapeutic strategy.